These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 24900217)

  • 41. Design, synthesis, and biological evaluation of novel pan agonists of FFA1, PPARγ and PPARδ.
    Li Z; Zhou Z; Deng F; Li Y; Zhang D; Zhang L
    Eur J Med Chem; 2018 Nov; 159():267-276. PubMed ID: 30296685
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Design, synthesis, and biological evaluations of phenylpropiolic acid derivatives as novel GPR40 agonists.
    Jiang XW; Jiang BE; Liu H; Liu ZT; Hu LL; Liu M; Lu W; Zhang HK
    Eur J Med Chem; 2018 Oct; 158():123-133. PubMed ID: 30212763
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Discovery of novel pyrrole-based scaffold as potent and orally bioavailable free fatty acid receptor 1 agonists for the treatment of type 2 diabetes.
    Li Z; Pan M; Su X; Dai Y; Fu M; Cai X; Shi W; Huang W; Qian H
    Bioorg Med Chem; 2016 May; 24(9):1981-7. PubMed ID: 27020683
    [TBL] [Abstract][Full Text] [Related]  

  • 44. SCO-267, a GPR40 Full Agonist, Improves Glycemic and Body Weight Control in Rat Models of Diabetes and Obesity.
    Ueno H; Ito R; Abe SI; Ookawara M; Miyashita H; Ogino H; Miyamoto Y; Yoshihara T; Kobayashi A; Tsujihata Y; Takeuchi K; Watanabe M; Yamada Y; Maekawa T; Nishigaki N; Moritoh Y
    J Pharmacol Exp Ther; 2019 Aug; 370(2):172-181. PubMed ID: 31182471
    [TBL] [Abstract][Full Text] [Related]  

  • 45. FFA1-selective agonistic activity based on docking simulation using FFA1 and GPR120 homology models.
    Takeuchi M; Hirasawa A; Hara T; Kimura I; Hirano T; Suzuki T; Miyata N; Awaji T; Ishiguro M; Tsujimoto G
    Br J Pharmacol; 2013 Apr; 168(7):1570-83. PubMed ID: 22639973
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Design, synthesis and structure-activity relationship studies of novel free fatty acid receptor 1 agonists bearing amide linker.
    Yang J; Li Z; Li H; Liu C; Wang N; Shi W; Liao C; Cai X; Huang W; Qian H
    Bioorg Med Chem; 2017 Apr; 25(8):2445-2450. PubMed ID: 28285923
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Design, synthesis and Structure-activity relationship studies of new thiazole-based free fatty acid receptor 1 agonists for the treatment of type 2 diabetes.
    Li Z; Qiu Q; Xu X; Wang X; Jiao L; Su X; Pan M; Huang W; Qian H
    Eur J Med Chem; 2016 May; 113():246-57. PubMed ID: 26945112
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Activation of FFA1 mediates GLP-1 secretion in mice. Evidence for allosterism at FFA1.
    Xiong Y; Swaminath G; Cao Q; Yang L; Guo Q; Salomonis H; Lu J; Houze JB; Dransfield PJ; Wang Y; Liu JJ; Wong S; Schwandner R; Steger F; Baribault H; Liu L; Coberly S; Miao L; Zhang J; Lin DC; Schwarz M
    Mol Cell Endocrinol; 2013 Apr; 369(1-2):119-29. PubMed ID: 23403053
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Free-fatty acid receptor-1 (FFA1/GPR40) promotes papillary RCC proliferation and tumor growth via Src/PI3K/AKT/NF-κB but suppresses migration by inhibition of EGFR, ERK1/2, STAT3 and EMT.
    Karmokar PF; Moniri NH
    Cancer Cell Int; 2023 Jun; 23(1):126. PubMed ID: 37355607
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Design, synthesis, and evaluation of a series of novel phenylpropanoic acid derivatives agonists for the FFA1.
    Yang J; Gu E; Yan T; Shen D; Feng B; Tang C
    Chem Biol Drug Des; 2019 May; 93(5):900-909. PubMed ID: 30657643
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Point mutation of Ffar1 abrogates fatty acid-dependent insulin secretion, but protects against HFD-induced glucose intolerance.
    Sabrautzki S; Kaiser G; Przemeck GKH; Gerst F; Lorza-Gil E; Panse M; Sartorius T; Hoene M; Marschall S; Häring HU; Hrabě de Angelis M; Ullrich S
    Mol Metab; 2017 Oct; 6(10):1304-1312. PubMed ID: 29031729
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The Role and Future of FFA1 as a Therapeutic Target.
    Ghislain J; Poitout V
    Handb Exp Pharmacol; 2017; 236():159-180. PubMed ID: 27807697
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Reevaluation of fatty acid receptor 1 as a drug target for the stimulation of insulin secretion in humans.
    Wagner R; Kaiser G; Gerst F; Christiansen E; Due-Hansen ME; Grundmann M; Machicao F; Peter A; Kostenis E; Ulven T; Fritsche A; Häring HU; Ullrich S
    Diabetes; 2013 Jun; 62(6):2106-11. PubMed ID: 23378609
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Polar aromatic periphery increases agonist potency of spirocyclic free fatty acid receptor (GPR40) agonists inspired by LY2881835.
    Krasavin M; Lukin A; Bagnyukova D; Zhurilo N; Golovanov A; Zozulya S; Zahanich I; Moore D; Tikhonova IG
    Eur J Med Chem; 2017 Feb; 127():357-368. PubMed ID: 28076825
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Lack of GPR40/FFAR1 does not induce diabetes even under insulin resistance condition.
    Matsuda-Nagasumi K; Takami-Esaki R; Iwachidow K; Yasuhara Y; Tanaka H; Ogi K; Nakata M; Yano T; Hinuma S; Taketomi S; Odaka H; Kaisho Y
    Diabetes Obes Metab; 2013 Jun; 15(6):538-45. PubMed ID: 23331570
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Regulation of cell survival through free fatty acid receptor 1 (FFA1) and FFA4 induced by endothelial cells in osteosarcoma cells.
    Minami K; Ueda N; Ishimoto K; Tsujiuchi T
    J Recept Signal Transduct Res; 2020 Apr; 40(2):181-186. PubMed ID: 32026734
    [TBL] [Abstract][Full Text] [Related]  

  • 57. GPR40 agonists for the treatment of type 2 diabetes mellitus: The biological characteristics and the chemical space.
    Chen C; Li H; Long YQ
    Bioorg Med Chem Lett; 2016 Dec; 26(23):5603-5612. PubMed ID: 27825762
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Discovery of phenylsulfonyl acetic acid derivatives with improved efficacy and safety as potent free fatty acid receptor 1 agonists for the treatment of type 2 diabetes.
    Li Z; Liu C; Xu X; Qiu Q; Su X; Dai Y; Yang J; Li H; Shi W; Liao C; Pan M; Huang W; Qian H
    Eur J Med Chem; 2017 Sep; 138():458-479. PubMed ID: 28689096
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Conjugated linoleic acids mediate insulin release through islet G protein-coupled receptor FFA1/GPR40.
    Schmidt J; Liebscher K; Merten N; Grundmann M; Mielenz M; Sauerwein H; Christiansen E; Due-Hansen ME; Ulven T; Ullrich S; Gomeza J; Drewke C; Kostenis E
    J Biol Chem; 2011 Apr; 286(14):11890-4. PubMed ID: 21339298
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Discovery of 3-aryl-3-ethoxypropanoic acids as orally active GPR40 agonists.
    Takano R; Yoshida M; Inoue M; Honda T; Nakashima R; Matsumoto K; Yano T; Ogata T; Watanabe N; Toda N
    Bioorg Med Chem Lett; 2014 Jul; 24(13):2949-53. PubMed ID: 24835985
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.